Severe laryngeal and pulmonary tuberculosis under anti-TNF-α therapy
نویسندگان
چکیده
منابع مشابه
Laryngeal tuberculosis without pulmonary involvement
Background: Tuberculosis of the larynx is a rare form of tuberculosis. Patients usually present with hoarseness or dysphagia and other nonspecific constitutional symptoms like fever or localized pain. In this study, we present a case of primary vocal cord lesion with tuberculosis. Case presentation: A 72 year old man presented with hoarseness of voice, low grade fever, and night sweating with i...
متن کاملTuberculosis in Juvenile Idiopathic arthritis under Anti-TNF therapy
Pt 1 M / 18 pJIA 18 no ETN 24 m INH No Pt 2 F/ 20 oJIA 12 no ADA 24 m INH No Pt 3 F / 7 pJIA 6 no ETN 11 m INH INF Pt 4 M / 13 sJIA 13 no IFX 1 m INH No Pt 5 F / 14 pJIA 10 Pulmonar involvement IFX 6 m 4 drugs ETN Pt 6 F / 17 pJIA 13 Pulmonar involvement IFX 24 m 4 drugs No Pt 7 F / 12 pJIA 13 Pulmonar involvement ETN 30 m 4 drugs ETN Espada et al. Pediatric Rheumatology 2011, 9(Suppl 1):P72 ht...
متن کاملAnti-TNF-α therapy in membranous glomerulonephritis
A 43-year-old woman with a history of psoriasis vulgaris was admitted for nephrotic syndrome that had started 6 months before. Renal biopsy revealed membranous glomerulonephritis (MGN). She did not receive any therapy for MGN. Two months later she started therapy for psoriasis with adalimumab, which resulted in disappearance of psoriatic skin lesions with progressive reduction of 24h proteinuri...
متن کاملAnti-TNF-α Therapy for Ankylosing Spondylitis
BACKGROUND This review evaluated the safety and efficacy of etanercept in patients with ankylosing spondylitis (AS). METHODS Of 59 patients with AS, this study reviewed 11 patients who were refractory to conventional therapy and treated with etanercept from September 2005 to January 2008. The mean follow-up duration was 13.6 months. The general improvement was evaluated by the Bath Ankylosing...
متن کاملAnti-TNF therapy in Jordan: a focus on severe infections and tuberculosis
BACKGROUND A high rate of infection has been reported in patients receiving treatment with anti-tumor necrosis factor (anti-TNF). This study describes the rate of and risk factors for serious infections in patients receiving anti-TNF agents in Jordan. METHODS This retrospective observational study was conducted at a large tertiary referral center in the north of Jordan. Between January 2006 a...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International Journal of Infectious Diseases
سال: 2018
ISSN: 1201-9712
DOI: 10.1016/j.ijid.2018.04.797